As an aid in the search for effective drugs against the HIV-1 virus that causes AIDS, a convenient radiopeptidase assay is proposed to be used in the screening for inhibitors of this enzyme responsible for infectivity. The HIV-1 aspartyl proteinase, one of the 3 functional enzymes of the retrovirus, clips the translated gag-pol polypeptide (viral gene product) into the mature virions in the infected cell. Inhibition of this enzyme prevents the cellular multiplication of infected virions. A sensitive biochemical assay for this enzyme is designed using a radiolabeled substrate that when cleaved by the aspartyl proteinase generates a labeled peptide fragment that is easily counted in solution. We propose to establish and optimize the assay, as well as to start screening for inhibitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI033255-01A1
Application #
3489658
Study Section
Special Emphasis Panel (SSS (B9))
Project Start
1993-05-01
Project End
1994-04-30
Budget Start
1993-05-01
Budget End
1994-04-30
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Peptide Technologies Corporation
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877